ZymoGenetics The Future of Protein Medicines

ZGEN: NASDAQ GM
Stock Quote
Last: $8.04
Change: $-0.31
Volume: 290,471
As of Jul 3 2008 1:00PM ET
Minimum 20 minutes delayed
ANNUAL REPORT





What's New
PEG-IFN lambda (IL-29) EASL presentation
PEG-Interferon Lambda Phase 1a Results
News Releases
ZymoGenetics Secures $100 Million Funding Commitment
ZymoGenetics to Webcast Presentation at Piper Jaffray London Conference
ZymoGenetics Names Heather Franklin Senior Vice President of Business Development
Upcoming Events
ZymoGenetics will issue Q2 financial results on August 5, 2008 (after market)
Webcast Presentation
Replay
ZymoGenetics Business Transaction Update
June 30, 2008, 10:30 AM ET
Replay
ZymoGenetics Inc. at Piper Jaffray Europe Conference
June 25, 2008, 11:20 AM UKT
Replay
ZymoGenetics Inc. at Needham & Company Biotechnology and Medical Technology Conference
June 11, 2008, 11:30 AM ET
Replay
ZymoGenetics Inc. Analyst Meeting
December 13, 2007, 10:00 AM ET


Home Site Map Contact Terms & Conditions Glossary
copyright © 2003 - 2008 ZymoGenetics built by
Axis Studios